Fidelity MSCI Health Care Index ETF
Latest Fidelity MSCI Health Care Index ETF News and Updates
How Allergan’s International Segment Performed in 2Q17
Allergan’s (AGN) international business includes total revenues from the sales of branded products as well as aesthetics products outside the US markets.
Pfizer on the Street: Analyst Recommendations after 2Q17
As of July 31, 2017, of the 22 analysts tracking Pfizer, ten recommend a “buy” for the stock, while 11 recommend a “hold,” and one recommends a “sell.”
Johnson & Johnson: Medical Devices in 2Q17
Medical devices segment Johnson & Johnson’s (JNJ) medical devices segment grew ~4.9% to ~$6.7 billion for 2Q17, compared with $6.4 billion in 2Q16. This rise included an operational increase of 5.9%, and was offset by a 1% impact of foreign exchange. Cardiovascular care franchise Cardiovascular care franchise sales rose 11.3% to $523 million for 2Q17. This […]
How Eli Lilly’s Taltz Performed in Clinical Trials
On June 15, 2017, Eli Lilly announced data from a study that evaluated the safety and efficacy of Taltz in patients with active psoriatic arthritis.
What Do Analysts Expect from Merck’s 1Q17 Earnings?
Merck and Co. (MRK) will release its 1Q17 earnings on May 2, 2017. Analysts’ estimates show EPS of $0.83 on revenues of $9.25 billion for 1Q17.